Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Liang

Showing results (41-50 of 270) with videos related to

Pageof 27
Sort By:
Angewandte Chemie (International Ed. in English)|September 23, 2014
C(sp³)-¹⁸F bond formation by transition-metal-based [¹⁸F]fluorinationSteven H Liang, Neil Vasdev
ACS Medicinal Chemistry Letters|August 20, 2025
Preparation of Novel PARP1 Inhibitors and Their Use in Cancer TreatmentXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) Inhibitors for Cancer TreatmentXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Substituted Aryl Sulfonamides and Sulfuric Diamides As Transglutaminase 2 InhibitorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel 2,4,6-Trisubstituted 1,3,5-Triazines as CX3CR1 Modulators for the Treatment of Cardiovascular DisordersTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|July 16, 2025
Synthesis of Novel Substituted <i>N</i>‑Heterocycles and Their Use of Selective Poly(ADP-ribose) Polymerase 1 (PARP1) InhibitorsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|July 16, 2025
Selective Modulation of the GluN2B/C/D Containing <i>N</i>‑Methyl‑d‑Aspartate Receptors: A New Frontier in Targeted NeurotherapeuticsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|October 15, 2025
Development of Novel Compounds and Methods for Treatment of PARPs Mediated DiseaseXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational MedicineTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Nonpeptide as Oxytocin Receptor AgonistYinlong Li, Steven H Liang
Pageof 27

Showing results (41-50 of 270) with videos related to

Sort By:
Pageof 27
Angewandte Chemie (International Ed. in English)|September 23, 2014
C(sp³)-¹⁸F bond formation by transition-metal-based [¹⁸F]fluorinationSteven H Liang, Neil Vasdev
ACS Medicinal Chemistry Letters|August 20, 2025
Preparation of Novel PARP1 Inhibitors and Their Use in Cancer TreatmentXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) Inhibitors for Cancer TreatmentXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Substituted Aryl Sulfonamides and Sulfuric Diamides As Transglutaminase 2 InhibitorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel 2,4,6-Trisubstituted 1,3,5-Triazines as CX3CR1 Modulators for the Treatment of Cardiovascular DisordersTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|July 16, 2025
Synthesis of Novel Substituted <i>N</i>‑Heterocycles and Their Use of Selective Poly(ADP-ribose) Polymerase 1 (PARP1) InhibitorsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|July 16, 2025
Selective Modulation of the GluN2B/C/D Containing <i>N</i>‑Methyl‑d‑Aspartate Receptors: A New Frontier in Targeted NeurotherapeuticsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|October 15, 2025
Development of Novel Compounds and Methods for Treatment of PARPs Mediated DiseaseXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational MedicineTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Nonpeptide as Oxytocin Receptor AgonistYinlong Li, Steven H Liang
Pageof 27